JAK3 and Parkinson disease: Compared to the MCAO groups, the protein expressions of phosphorylated‐JAK3, phosphorylated‐STAT3, and HIF‐1α were mitigated by PD treatment in a dose‐dependent manner (Figures 7E–H and 8).